Last reviewed · How we verify
NCT03932396: HONEST
A Novel Hepatitis c micrOelimination Program in Non imprisonEd SenTenced With Alternative Measures
trial testing Observational study in Hepatotropic Virus Infection in 1,000 participants. Status unknown.
1 March 2021
Quick facts
| Lead sponsor | Instituto de Investigación Marqués de Valdecilla |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 10 May 2019 |
| Primary completion | 1 March 2021 |
| Estimated completion | 31 March 2021 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Observational study — full drug profile →
Conditions studied
- Hepatotropic Virus Infection — all drugs for Hepatotropic Virus Infection →
- Addictive Behaviours o Conducts — all drugs for Addictive Behaviours o Conducts →
- Mental Disease — all drugs for Mental Disease →
- People Sentenced to Non-custodial Sentences — all drugs for People Sentenced to Non-custodial Sentences →
Sponsor
Instituto de Investigación Marqués de Valdecilla — full company profile →
Who can join
Adults 18 to 79, any sex, with Hepatotropic Virus Infection or Addictive Behaviours o Conducts. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to carry out a Micro-elimination program for HCV infection in a vulnerable population (people sentenced to non-custodial sentences). This group shares certain peculiarities with the prison population (vulnerability, addictions, mental disorders, etc.), is three times higher than the imprisoned population, and is regularly attended by Social Insertion Centers (CIS) in Spain. An additional objective is to link these people with the specific plans of the Government of Cantabria (Chronicity Plan, Care for Serious Mental Disorders, Harm Reduction Programs and the Center for Attention to Drug Addicts) as well as the Extended Bridge Program for Penitentiary Institutions, implementing the figure of a Navigator (a specialized professional in charge of helping subjects overcome barriers). It is an observational study based on the screening of disease in accordance with the recommendations of the health authorities. Once detected, patients will be referred to the corresponding specialized care following the usual clinical practice.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences.
Cabezas J, Llerena S, Mateo M, Álvarez R, et al · · 2021 · cited 20× · PMID 34068955 · DOI 10.3390/diagnostics11050877
Verify or expand the search:
- PubMed search for NCT03932396
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Observational study
Trials testing the same drug.
- NCT07255443 — Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital · not yet recruiting
- NCT07343713 — Correlation Between the Degree of Middle Ear Pressure and the Eustachian Tube Dimensions : Radiological Study · not yet recruiting
- NCT07192991 — Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America · not yet recruiting
- NCT07219927 — Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States: · recruiting
- NCT06244238 — A Study on the Relationship Between Job Satisfaction and Retention Intentions of Emergency Room Nurses · unknown
Other Instituto de Investigación Marqués de Valdecilla trials
Trials by the same sponsor.
- NCT07113184 — Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke · NA · not yet recruiting
- NCT06908785 — Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM) · recruiting
- NCT05622526 — Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoho · Phase 2 · unknown
- NCT06753578 — Effectiveness of an ACT-Based Cognitive Intervention on Quality of Life and Cognitive Function in Elderly Residents With · NA · recruiting
- NCT06615271 — Pressure Injuries in the Operating Room and Their Perioperative Incidence in Patients Undergoing Neurosurgery. · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03932396 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Investigación Marqués de Valdecilla
- Last refreshed: 30 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03932396.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing